MedicaidPrior AuthMedium impact
KMAP BULLETIN: Pharmaceutical Prior Authorization Updates – February 2026
Kansas Medicaid (KanCare)·KS·Provider Bulletin
Effective date
Mar 1, 2026
We identified it
Jun 21, 2026
Summary
Effective March 1, 2026, six specific medications will require prior authorization under Kansas Medicaid (KMAP) Preferred Drug List, including Cibinqo, Tryptyr, Lynkuet, Veozah, Symbravo, and Treximet. Implementation timing may vary by KanCare managed care organization.
Action Required
By March 1, 2026: Clinical and billing staff must implement prior authorization requirements for six specified medications (Abrocitinib/Cibinqo, Acoltremon/Tryptyr, Elinzanetant/Lynkuet, Fezolinetant/Veozah, Meloxicam/rizatriptan/Symbravo, Sumatriptan/Naproxen/Treximet) for Kansas Medicaid patients. Update prescription workflows and EMR alerts to flag these medications for prior auth. Monitor KanCare MCO implementation dates as they may vary from the state effective date.